| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2838185 | Cardiovascular Revascularization Medicine | 2008 | 6 Pages |
Abstract
RI is an independent predictor of 30-day and 12-month MACE and death after PCI in patients with stable and unstable coronary syndromes, even with widespread use of DES. eGFR should be used to help risk-stratify patients undergoing PCI.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
James A. Shaw, Nick Andrianopoulos, Stephen Duffy, Anthony S. Walton, David Clark, Robert Lew, Martin Sebastian, Gishel New, Angela Brennan, Chris Reid, Andrew E. Ajani,